ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 77 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,000 | -36.4% | 5,273 | -47.3% | 0.00% | – |
Q1 2023 | $22,000 | -84.7% | 10,000 | -16.7% | 0.00% | – |
Q4 2022 | $144,000 | -7.1% | 12,000 | -50.0% | 0.00% | – |
Q3 2022 | $155,000 | +46.2% | 23,977 | +3.2% | 0.00% | – |
Q2 2022 | $106,000 | -21.5% | 23,242 | +49.1% | 0.00% | – |
Q1 2022 | $135,000 | -51.1% | 15,592 | -19.2% | 0.00% | – |
Q4 2021 | $276,000 | -15.9% | 19,305 | +29.3% | 0.00% | – |
Q3 2021 | $328,000 | +543.1% | 14,926 | +289.3% | 0.00% | – |
Q2 2021 | $51,000 | +155.0% | 3,834 | +91.7% | 0.00% | – |
Q1 2021 | $20,000 | +5.3% | 2,000 | -55.6% | 0.00% | – |
Q4 2020 | $19,000 | +111.1% | 4,500 | +28.6% | 0.00% | – |
Q3 2020 | $9,000 | -47.1% | 3,500 | -25.5% | 0.00% | – |
Q2 2020 | $17,000 | +13.3% | 4,698 | 0.0% | 0.00% | – |
Q1 2020 | $15,000 | -37.5% | 4,698 | +4.4% | 0.00% | – |
Q4 2019 | $24,000 | +50.0% | 4,500 | -7.8% | 0.00% | – |
Q3 2019 | $16,000 | +166.7% | 4,883 | +225.5% | 0.00% | – |
Q2 2019 | $6,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
Q1 2019 | $6,000 | +20.0% | 1,500 | 0.0% | 0.00% | – |
Q4 2018 | $5,000 | -28.6% | 1,500 | -1.6% | 0.00% | – |
Q3 2018 | $7,000 | -36.4% | 1,524 | +1.6% | 0.00% | – |
Q2 2018 | $11,000 | +10.0% | 1,500 | 0.0% | 0.00% | – |
Q1 2018 | $10,000 | -28.6% | 1,500 | 0.0% | 0.00% | – |
Q4 2017 | $14,000 | +180.0% | 1,500 | +200.0% | 0.00% | – |
Q3 2017 | $5,000 | +25.0% | 500 | 0.0% | 0.00% | – |
Q2 2017 | $4,000 | +33.3% | 500 | 0.0% | 0.00% | – |
Q1 2017 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q4 2016 | $3,000 | -25.0% | 500 | 0.0% | 0.00% | – |
Q3 2016 | $4,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q2 2016 | $4,000 | +33.3% | 500 | 0.0% | 0.00% | – |
Q1 2016 | $3,000 | -50.0% | 500 | -28.6% | 0.00% | – |
Q4 2015 | $6,000 | +500.0% | 700 | +250.0% | 0.00% | – |
Q3 2015 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q2 2015 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q1 2015 | $1,000 | -96.7% | 200 | -97.0% | 0.00% | – |
Q4 2014 | $30,000 | +2900.0% | 6,589 | +6489.0% | 0.00% | – |
Q3 2014 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q2 2014 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q1 2014 | $1,000 | -66.7% | 100 | -50.0% | 0.00% | – |
Q4 2013 | $3,000 | +200.0% | 200 | 0.0% | 0.00% | – |
Q3 2013 | $1,000 | -50.0% | 200 | 0.0% | 0.00% | – |
Q2 2013 | $2,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MORGAN JESS S & CO INC | 576,317 | $1,504,000 | 1.50% |
Phoenix Holdings Ltd. | 197,763 | $483,000 | 0.02% |
Frontier Wealth Management LLC | 71,900 | $188,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 19,659 | $51,000 | 0.01% |
Rossmore Private Capital | 15,061 | $39,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 98,486 | $255,000 | 0.01% |
Virtu Financial LLC | 10,450 | $27,000 | 0.01% |
BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $15,000 | 0.01% |
Sterling Investment Advisors, Ltd. | 3,150 | $8,000 | 0.00% |
Qube Research & Technologies Ltd | 75,395 | $197,000 | 0.00% |